TY - JOUR
T1 - The role of endoscopy in the management of GERD
AU - ASGE Standards of Practice Committee
AU - Muthusamy, V. Raman
AU - Lightdale, Jenifer R.
AU - Acosta, Ruben D.
AU - Chandrasekhara, Vinay
AU - Chathadi, Krishnavel V.
AU - Eloubeidi, Mohamad A.
AU - Fanelli, Robert D.
AU - Fonkalsrud, Lisa
AU - Faulx, Ashley L.
AU - Khashab, Mouen A.
AU - Saltzman, John R.
AU - Shaukat, Aasma
AU - Wang, Amy
AU - Cash, Brooks
AU - Dewitt, John M.
N1 - Publisher Copyright:
Copyright © 2015 by the American Society for Gastrointestinal Endoscopy.
PY - 2015/6/1
Y1 - 2015/6/1
N2 - We recommend that uncomplicated GERD be diagnosed on the basis of typical symptoms without the use of diagnostic testing, including EGD. We recommend EGD for patients who have symptoms suggesting complicated GERD or alarm symptoms. We recommend that EGD not be routinely performed solely for the assessment of extraesophageal GERD symptoms. We recommend that endoscopic findings of reflux esophagitis be classified according to an accepted grading scale or described in detail. We suggest that repeat EGD be performed in patients with severe erosive esophagitis after at least an 8-week course of PPI therapy to exclude underlying BE or dysplasia. We recommend against obtaining tissue samples from endoscopically normal tissue to diagnose GERD or exclude BE in adults. We suggest that endoscopy be considered in patients with multiple risk factors for Barrett's esophagus. We recommend that tissue samples be obtained to confirm endoscopically suspected Barrett's esophagus. We suggest that endoscopic antireflux therapy be considered for selected patients with uncomplicated GERD after careful discussion with the patient regarding potential adverse effects, benefits, and other available therapeutic options.
AB - We recommend that uncomplicated GERD be diagnosed on the basis of typical symptoms without the use of diagnostic testing, including EGD. We recommend EGD for patients who have symptoms suggesting complicated GERD or alarm symptoms. We recommend that EGD not be routinely performed solely for the assessment of extraesophageal GERD symptoms. We recommend that endoscopic findings of reflux esophagitis be classified according to an accepted grading scale or described in detail. We suggest that repeat EGD be performed in patients with severe erosive esophagitis after at least an 8-week course of PPI therapy to exclude underlying BE or dysplasia. We recommend against obtaining tissue samples from endoscopically normal tissue to diagnose GERD or exclude BE in adults. We suggest that endoscopy be considered in patients with multiple risk factors for Barrett's esophagus. We recommend that tissue samples be obtained to confirm endoscopically suspected Barrett's esophagus. We suggest that endoscopic antireflux therapy be considered for selected patients with uncomplicated GERD after careful discussion with the patient regarding potential adverse effects, benefits, and other available therapeutic options.
UR - http://www.scopus.com/inward/record.url?scp=84929605975&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84929605975&partnerID=8YFLogxK
U2 - 10.1016/j.gie.2015.02.021
DO - 10.1016/j.gie.2015.02.021
M3 - Article
C2 - 25863867
AN - SCOPUS:84929605975
SN - 0016-5107
VL - 81
SP - 1305
EP - 1310
JO - Gastrointestinal endoscopy
JF - Gastrointestinal endoscopy
IS - 6
ER -